Head and Neck Pathology

, Volume 10, Issue 3, pp 405–413 | Cite as

A Case of Primary Mammary Analog Secretory Carcinoma (MASC) of the Thyroid Masquerading as Papillary Thyroid Carcinoma: Potentially More than a One Off

  • S. Reynolds
  • M. Shaheen
  • G. Olson
  • M. Barry
  • J. Wu
  • T. BocklageEmail author
Case Report


We present the second reported mammary analog secretory carcinoma (MASC) apparently arising in the thyroid and propose a potential close relationship to ETV6-NTRK3 fusion papillary thyroid carcinoma. The patient, a 36 year old woman, presented with a neck mass of 1 year’s duration. Imaging studies showed a tumor involving most of the thyroid with enlarged regional lymph nodes. FNA biopsy yielded a diagnosis of “papillary thyroid carcinoma”. Resection revealed a 4.5 cm infiltrative tumor. Final diagnosis was “papillary thyroid carcinoma (PTC) consistent with diffuse sclerosing variant” with positive lymph nodes (2+/4) and margins. Histologic features included mixed microcystic, solid, follicular and papillary architecture, prominent nucleoli, abundant nuclear grooves and rare nuclear pseudo-inclusions. Despite radioactive iodine, radiotherapy and multiagent chemotherapy, the patient progressed over 6 years with local recurrence and additional lymph node involvement finally developing widespread distant metastases. Prompted by the breast carcinoma-like histopathology of a metastasis, immunohistochemical staining was performed and revealed strong expression of GATA3 and mammaglobin with no reactivity for thyroglobulin or TTF-1. The original tumor was then tested and showed the same immunoprofile. RT-PCR confirmed the presence of an ETV6-NTRK3 fusion consistent with a diagnosis of MASC. Our patient’s clinical, imaging and morphologic features remarkably mimicked papillary thyroid carcinoma. At the molecular level, the ETV6-NTRK3 fusion in this patient involved exons reported in the rare “papillary thyroid carcinoma” with this translocation. Given the immunophenotype of this case, it is possible that at least some ETV6-NTRK3 fusion positive PTC are actually MASC masquerading as papillary thyroid carcinoma.


MASC Thyroid carcinoma Papillary thyroid carcinoma ETV6-NTRK3 fusion Genetics 


  1. 1.
    Skálová A, Vanecek T, Sima R, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34:599–608.PubMedGoogle Scholar
  2. 2.
    Majewska H, Skálová A, Stodulski D, et al. Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement. Virchows Arch. 2015;466(3):245–54.CrossRefPubMedGoogle Scholar
  3. 3.
    Connor A, Perez-Ordoñez B, Shago M, et al. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity. Am J Surg Pathol. 2012;36:27–34.CrossRefPubMedGoogle Scholar
  4. 4.
    Projetti F, Lacroix-Triki M, Serrano E, et al. A comparative immunohistochemistry study of diagnostictools in salivary gland tumors: usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma? J Oral Pathol Med. 2015;44:244–51.CrossRefPubMedGoogle Scholar
  5. 5.
    Bishop JA. Unmasking MASC: bringing to light the unique morphologic, immunohistochemical and genetic features of the newly recognized mammary analogue secretory carcinoma of salivary glands. Head Neck Pathol. 2013;7:35–9.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Skálová A, Vanecek T, Majewska H, et al. Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, β-catenin, EGFR, and CCND1 genes. Am J Surg Pathol. 2014;38:23–33.CrossRefPubMedGoogle Scholar
  7. 7.
    Stevens TM, Kovalovsky AO, Velosa C, et al. Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study. Mod Pathol. 2015;28:1084–100.CrossRefPubMedGoogle Scholar
  8. 8.
    Skálová A, Vanacek T, Simpson RH, et al. Mammary analogue secretory carcinoma of salivary glands: molecular analysis of 25 ETV6 gene rearranged tumors with lack of detection of classical ETV6-NTRK3 fusion transcript by standart RT-PCR: report of four cases harboring ETV6-X gene fusion. Am J Surg Pathol. 2016;40:3–13.CrossRefPubMedGoogle Scholar
  9. 9.
    Tognon C, Knezevich SR, Huntsman D, et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2002;2:367–76.CrossRefPubMedGoogle Scholar
  10. 10.
    Rubin BP, Chen CJ, Morgan TW, et al. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol. 1998;153:1451–8.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Knezevich SR, McFadden DE, Tao W, et al. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet. 1998;18:184–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Eguchi M, Eguchi-Ishimae M, Tojo A, et al. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood. 1999;93:1355–63.PubMedGoogle Scholar
  13. 13.
    Leeman-Neill RJ, Kelly LM, Liu P, et al. ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer. Cancer. 2014;120:799–807.CrossRefPubMedGoogle Scholar
  14. 14.
    Hsieh M-S, Chou Y-H, Yeh S-J, et al. Papillary-cystic pattern is characteristic in mammary analogue secretory carcinomas but is rarely observed in acinic cell carcinomas of the salivary gland. Virchows Arch. 2015;467:145–53.CrossRefPubMedGoogle Scholar
  15. 15.
    Lubitz CC, Economopoulos KP, Pawlak AC, et al. Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile. Thyroid. 2014;24(6):958–65.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Luo W, Lindley SW, Lindley PH, et al. Mammary analog secretory carcinoma of salivary gland with high-grade histology arising in hard palate, report of a case and review of literature. Int J Clin Exp Pathol. 2014;7:9008–22.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Skálová A. Mammary analog secretory carcinoma of salivary gland origin: an update and expanded morphological and immunohistochemical spectrum of recently described entity. Head Neck Pathol. 2013;7:S30–6.CrossRefPubMedGoogle Scholar
  18. 18.
    Costa V, Esposito R, Ziviello C, et al. New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma. Oncotarget. 2015;6:11242–51.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014;159:676–90.CrossRefGoogle Scholar
  20. 20.
    Santoro M, Carlomagno F. Oncogenic rearrangements driving ionizing radiation-associated human cancer. J Clin Invest. 2013;123:4566–8.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Ricarte-Filho JC, Li S, Garcia-Rendueles ME, et al. Identification of kinase fusion oncogenes in post-chernobyl radiation-induced thyroid cancers. J Clin Invest. 2013;123:4935–44.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Prasad ML, Vyas M, Home MJ, Virk RK, et al. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States. Cancer. 2016;122:1097–107.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • S. Reynolds
    • 1
  • M. Shaheen
    • 2
  • G. Olson
    • 3
  • M. Barry
    • 1
  • J. Wu
    • 1
  • T. Bocklage
    • 1
    Email author
  1. 1.Department of PathologyUniversity of New Mexico School of Medicine (UNM SOM)AlbuquerqueUSA
  2. 2.Division of Hematology/Oncology, Department of Internal MedicineUniversity of New Mexico School of Medicine (UNM SOM)AlbuquerqueUSA
  3. 3.Division of Otolaryngology, Department of SurgeryUniversity of New Mexico School of Medicine (UNM SOM)AlbuquerqueUSA

Personalised recommendations